Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,772 | -9,575 | -17,292 | -18,471 | -48,977 |
| Depreciation Amortization | 201 | 338 | 408 | 7,889 | 39,361 |
| Accounts payable and accrued liabilities | -133 | 233 | N/A | N/A | N/A |
| Other Working Capital | -296 | -423 | -175 | -218 | 1,185 |
| Other Operating Activity | 859 | 1,702 | 2,964 | -6,347 | -3,026 |
| Operating Cash Flow | $-8,142 | $-7,726 | $-14,094 | $-17,147 | $-11,458 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 12 | -584 | -190 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 3,055 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -675 |
| Investing Cash Flow | $N/A | $N/A | $12 | $-584 | $2,191 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,580 | 6,051 | N/A | 17,222 | 24,900 |
| Other Financing Activity | 0 | 1,623 | -1,343 | 958 | 0 |
| Financing Cash Flow | $10,580 | $7,674 | $-1,343 | $18,180 | $24,900 |
| Exchange Rate Effect | -2 | 5 | -10 | -81 | 145 |
| Beginning Cash Position | 2,241 | 2,288 | 17,724 | 17,356 | 1,579 |
| End Cash Position | 4,678 | 2,241 | 2,288 | 17,724 | 17,356 |
| Net Cash Flow | $2,437 | $-47 | $-15,436 | $368 | $15,778 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,142 | -7,726 | -14,094 | -17,147 | -11,458 |
| Capital Expenditure | N/A | N/A | -5 | -584 | -190 |
| Free Cash Flow | -8,142 | -7,726 | -14,100 | -17,731 | -11,647 |